Literature DB >> 7118326

Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.

M Lesne, F Clerckx-Braun, P Duhoux, C van Ypersele de Strihou.   

Abstract

A new diuretic drug, torasemide, after oral or i. v. administration of 20 mg to six normal volunteers showed good bioavailability (greater than 91%). Its biologic half-life is about 2.5 h with a distribution volume of 180 ml/kg and a body clearance of 0.8 ml/min kg. The renal excretion represents only 25% of the total drug elimination. The excretion of water, sodium, potassium, and chloride parallels the renal excretion of torasemide. The diuretic action has a duration of 6 h, reaching its maxima during the 1st h after i. v. administration an during the 2nd h after oral administration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118326

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  19 in total

1.  Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure.

Authors:  H Spahn; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

4.  Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.

Authors:  E van Ganse; J Douchamps; F Deger; M Staroukine; A Verniory; A Herchuelz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Torasemide, a new potent diuretic. Double-blind comparison with furosemide.

Authors:  J Broekhuysen; F Deger; J Douchamps; H Ducarne; A Herchuelz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.

Authors:  A J Scheen; J C Vancrombreucq; J Delarge; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.

Authors:  L Dodion; Y Ambroes; N Lameire
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.

Authors:  Y Ambroes; I Ronflette; L Dodion
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.

Authors:  G Loute; A Adam; P Ers; C Heremans; B Willems
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Site of action of torasemide in man.

Authors:  R Cuvelier; P Pellegrin; M Lesne; C van Ypersele de Strihou
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.